开发和验证临床决策支持系统,以防止抗凝剂重复复制
Hendrike Dahmke1, Francisco Cabrera-Diaz2, Marc Heizmann3
1Hospital Pharmacy, Kantonsspital Aarau, 5000 Aarau, Switzerland.
International journal of medical informatics
|April 26, 2024
概括
一个新的临床决策支持系统 (CDSS) 显著减少了重复的抗凝剂处方及其持续时间,提高了患者的安全. 该系统通过检测抗凝剂重复 (AD) 来帮助预防药物错误.
科学领域:
- 医疗信息学 医疗信息学
- 临床药房 临床药房
- 患者安全 患者安全
背景情况:
- 意外重复的抗凝剂处方造成不良事件的重大风险.
- 临床决策支持系统 (CDSS) 为预防药物错误提供了一个解决方案.
- 复杂的算法对于CDSS来说至关重要,以避免警报疲劳.
研究的目的:
- 描述旨在防止抗凝固剂重复 (AD) 的CDSS的发展.
- 评估CDSS对ADS发生和持续时间的影响.
主要方法:
- 这是一个三阶段项目,涉及现状分析,临床药剂师开发算法,并集成到电子健康记录系统中.
- 在所有阶段对AD发病率和持续时间的回顾性分析.
- 详细分析第三阶段警报,包括接收率,敏感性和特异性.
主要成果:
- 减少了ADs从91 (第一阶段) 到57 (第三阶段) 的数量,并且平均AD持续时间从1.8日减少到1.1天.
- 与基线相比,在III期期间AD的相对风险降低了42%.
- 高警报接受率 (97%),计算灵敏度为87.4%和特异性为87.9%.
结论:
- 逐步开发和实施CDSS有效地减少了与抗凝剂重复相关的药物错误.
- 通过尽量减少ADS的频率和持续时间,CDSS显著提高了患者的安全性.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
687
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
687
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Nursing Clinical Information System
769
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
769
Pharmacovigilance
829
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
829


